Company
Violet Therapeutics
Violet is a therapeutics company leveraging the C-to-C Engine, a proprietary platform for the identification of cell-to-cell interactions with a specific focus on diseases of the central nervous system (CNS).
Also known as Violet Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Violet is a therapeutics company leveraging the C-to-C Engine, a proprietary platform for the identification of cell-to-cell interactions with a specific focus on diseases of the central nervous system (CNS). Our lead program is a small molecule inhibitor of EphB3, the first target identified by the C-to-C Engine. EphB3 is a receptor tyrosine kinase that mediates microglia-astrocyte interactions driving glial dysfunction in neurodegenerative disease.
Products
- Web
- C-to-C Engine
- Web
- small molecule inhibitor of EphB3
Loading relationship preview